Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 482pembrolizumab 456Magnetic Resonance Spectroscopy 419Carboplatin 322Cyclophosphamide 317Biopsy 270Cisplatin 263Radiotherapy 238Paclitaxel 227Gemcitabine 222Bevacizumab 214Nivolumab 190fludarabine 185venetoclax 172Drug Therapy 165Blood Specimen Collection 157Dexamethasone 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 138Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Surveys and Questionnaires 104

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × small molecule inhibitor THX-B × 1 year × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡